203 related articles for article (PubMed ID: 8755013)
1. Hypertension and CHD risk: whither alpha-1 blockers?
Pandit RB
Indian Heart J; 1996; 48(3):265-71. PubMed ID: 8755013
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive drug therapy and coronary heart disease risk.
Schoenberger JA
J Fam Pract; 1993 Jan; 36(1):70-3, 77-84. PubMed ID: 8419507
[TBL] [Abstract][Full Text] [Related]
3. Alpha blockers: a reassessment of their role in therapy.
Cauffield JS; Gums JG; Curry RW
Am Fam Physician; 1996 Jul; 54(1):263-6, 269-70. PubMed ID: 8677841
[TBL] [Abstract][Full Text] [Related]
4. [New findings on the use of specific alpha-1 adrenergic blockers in the treatment of high blood pressure].
Horký K
Vnitr Lek; 1991 Jun; 37(6):604-11. PubMed ID: 1680257
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
6. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient.
Pool JL
Br J Clin Pract Suppl; 1994 May; 74():8-12. PubMed ID: 8049119
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihypertensive drugs on lipid metabolism.
Leren P
Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive agents and cardiovascular risk factors.
Fodor JG
Clin Ther; 1986; 8(5):490-509. PubMed ID: 2876774
[TBL] [Abstract][Full Text] [Related]
9. [Alpha-adrenoceptor antagonist (blocker)].
Shigetomi S
Nihon Rinsho; 1997 Aug; 55(8):2055-60. PubMed ID: 9284423
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1 blockers: antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignored.
Waite MA
J Intern Med Suppl; 1991; 735():113-7. PubMed ID: 1675053
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes.
Glanz M; Garber AJ; Mancia G; Levenstein M
Int J Clin Pract; 2001 Dec; 55(10):694-701. PubMed ID: 11777296
[TBL] [Abstract][Full Text] [Related]
12. Metabolic changes during antihypertensive therapies.
Krone W; Nägele H
J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
14. [Drugs and arterial stiffness in hypertensive patients].
Laurent S
Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
Kincaid-Smith P
J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and lipid lowering effects of terazosin.
Rosenthal J
J Hum Hypertens; 1989 Dec; 3 Suppl 2():85-9; discussion 90-1. PubMed ID: 2575179
[TBL] [Abstract][Full Text] [Related]
17. The effect of alpha-blockers on cardiac function.
Antani JA
J Assoc Physicians India; 1998; Suppl 1():11-4. PubMed ID: 11229103
[No Abstract] [Full Text] [Related]
18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
19. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and coronary heart disease: a review of the evidence.
Lawes CM; Bennett DA; Lewington S; Rodgers A
Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
